Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Patterns and Patient-Reported Outcomes in Adult Type 2 Diabetes Patients Initiating Oral Monotherapy in Japan
jRCT1080223251Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co. Started Jun 2016; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080223251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223251.